Evidence map›Paper›PMID 32606313›Full record

ArticleNature communications2020

Author Correction: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension.

Hebah A Sindi, Giusy Russomanno, Sandro Satta, Vahitha B Abdul-Salam, Kyeong Beom Jo, Basma Qazi-Chaudhry, Alexander J Ainscough, Robert Szulcek, Harm Jan Bogaard, Claire C Morgan and 8 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Genes · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 6 countries.

Hebah A Sindi *National Heart and Lung Institute, Imperial College London, London, UK.
Giusy Russomanno *National Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-3378-5524
Sandro SattaNational Heart and Lung Institute, Imperial College London, London, UK.
Vahitha B Abdul-SalamNational Heart and Lung Institute, Imperial College London, London, UK.
Kyeong Beom JoNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-6254-2030
Basma Qazi-ChaudhryDepartment of Physics, King's College London UK, London, UK.ORCID http://orcid.org/0000-0001-5588-0947
Alexander J AinscoughNational Heart and Lung Institute, Imperial College London, London, UK.
Robert SzulcekAmsterdam UMC, VU University Medical Center, Department of Pulmonary Diseases, Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0450-7338
Harm Jan BogaardAmsterdam UMC, VU University Medical Center, Department of Pulmonary Diseases, Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands.
Claire C MorganNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-8191-3738
Soni S PullamsettiMax Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany.ORCID http://orcid.org/0000-0003-0440-8831
Mai M AlzaydiNational Heart and Lung Institute, Imperial College London, London, UK.
Christopher J RhodesNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-4962-3204
Roberto PivaMolecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.ORCID http://orcid.org/0000-0002-2273-3470
Christina A EichstaedtCentre for Pulmonary Hypertension, Thoraxclinic, Institute for Human Genetics, University of Heidelberg, Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7288-8297
Ekkehard GrünigCentre for Pulmonary Hypertension, Thoraxclinic, Institute for Human Genetics, University of Heidelberg, Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
Martin R WilkinsNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-3926-1171
Beata Wojciak-StothardNational Heart and Lung Institute, Imperial College London, London, UK. b.wojciak-stothard@imperial.ac.uk.ORCID http://orcid.org/0000-0002-6607-7372
Imperial College London · GBAmsterdam University Medical Centers · NLHeidelberg University · DEJustus-Liebig-Universität Gießen · DEKing Abdulaziz City for Science and Technology · SAKing's College London · GBLung Institute · USUniversity of Jeddah · SAUniversity of Turin · IT

Funding

British Heart Foundation PG/16/4/31849
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32606313
PMCPMC7327042
OpenAlexW3040315392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.